TrianglePUBLICATIONS · 35107876
Brentuximab vedotin in combination with bendamustine in pediatric patients or young adults with relapsed or refractory Hodgkin lymphoma.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Pediatr Blood Cancer
- Publication date
- 2022 Apr
- First author
- Vinti L
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Vinti L
- type
- Author
- name
- Pagliara D
- type
- Author
- name
- Buffardi S
- type
- Author
- name
- Di Ruscio V
- type
- Author
- name
- Stocchi F
- type
- Author
- name
- Mariggiò E
- type
- Author
- name
- Parasole R
- type
- Author
- name
- Di Matteo A
- type
- Author
- name
- Petruzziello F
- type
- Author
- name
- Paganelli V
- type
- Author
- name
- De Vito R
- type
- Author
- name
- Del Bufalo F
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Vinti L
- type
- Author
- name
- Pagliara D
- type
- Author
- name
- Buffardi S
- type
- Author
- name
- Di Ruscio V
- type
- Author
- name
- Stocchi F
- type
- Author
- name
- Mariggiò E
- type
- Author
- name
- Parasole R
- type
- Author
- name
- Di Matteo A
- type
- Author
- name
- Petruzziello F
- type
- Author
- name
- Paganelli V
- type
- Author
- name
- De Vito R
- type
- Author
- name
- Del Bufalo F
- type
- Author
- bibliography ids
- nci-bib-5cb47b19e799df98488996a4
- book metadata
- content sha256
- 6ea3912c9594ea7e29a8785174699ffba8cf496f64ecd0bdd743193d537de56d
- document type
- citation
- dois
- 10.1002/pbc.29557
- electronic publication date
- display
- 2022 Feb 2
- precision
- day
- year
- 2022
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:35107876
- immutable id
- pubmed:35107876@6ea3912c9594ea7e29a8785174699ffba8cf496f64ecd0bdd743193d537de56d
- journal
- abbreviation
- Pediatr Blood Cancer
- issn electronic
- 1545-5017
- issn print
- 1545-5009
- issue
- 4
- name
- Pediatric blood & cancer
- nlm unique id
- 101186624
- pages
- e29557
- volume
- 69
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 35107876
- provenance
- batch id
- 3f4d1914d2afe41e9e70
- provider
- NCBI PubMed ESummary
- record sha256
- fbd36351545f97636be052e723532b8f9908a8e895fd27a80cc963a501fd1d74
- response sha256
- 0ceeb248a527e54c6f72dd28d20f7abec08a973fe2e10de00bede4895add09e7
- retrieved at
- 2026-09-09T23:48:06.522634+00:00
- publication date
- display
- 2022 Apr
- precision
- month
- year
- 2022
- publication types
- Journal Article
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Brentuximab vedotin in combination with bendamustine in pediatric patients or young adults with relapsed or refractory Hodgkin lymphoma.
Preserved source evidence · Not medical advice